Join Assembly

ERS Assemblies

ERS Assemblies are the backbone of ERS. The Assemblies, and Groups within them, underpin all ERS scientific and educational activities and help drive ERS forward to achieving its mission. Each member has an intrinsic role within these groups to help set the agenda across all ERS activities.

Members can log in to ‘myERS’ and join one main group and up to two more groups to best suit your professional interest area. Members then become part of the nerve centre of ERS; voting for new leaders, shaping key activities such as the Congress programme and task forces, and being the first to hear about new opportunities and events in your professional interest area.

ERS Assembly 1: Clinical

Head: Felix JF. Herth

Secretary: Venerino Poletti

Assembly Early Career representative: Nicolas Kahn

Assembly 1 is a broad-based group for specialists based in hospitals and primary-care settings. Members are interested in addressing relevant clinical problems and in translating the latest research into daily practice.

Clinical Problems

Group 01.01
Chair: Thekkinkattil Mohan Kumar
Secretary: Laura Fregonese

Rehabilitation and Chronic Care

Group 01.02
Chair: Frits Franssen
Secretary: Guido Vagheggini

Imaging

Group 01.03
Chair: Aleksandar Grgic
Secretary: Johan Coolen

Interventional Pulmonology

Group 01.04
Chair: Jouke T. Annema
Secretary: Prashant Nemichand Chhajed

General Practice and Primary Care

Group 01.05
Chair: Hilary Pinnock
Secretary: Janwillem W. H. Kocks

ERS Assembly 2: Respiratory Intensive Care

Head: Raffaele Scala

Secretary: Leo Heunks

Assembly Early Career representative: Lieuwe Bos

Respiratory failure is the principal cause of intensive care admission. Although the field involves many specialties, there is a strong tradition of research and training from pulmonologists.
The Assembly is comprised of the following two groups:

Acute Critical Care

Group 02.01
Chair: Marcus Schultz
Secretary: Lígia Pires

Noninvasive Ventilatory Support

Group 02.02
Chair: Michael Dreher
Secretary: Winck Joao Carlos

ERS Assembly 3: Basic and translational sciences

Head: Pieter Hiemstra

Secretary: Catherine Greene

Assembly Early Career representative: Sabine Bartel

Assembly 3 provides a platform for interaction between basic scientists and practicing clinicians interested in the cellular and molecular mechanisms involved in healthy and diseased lungs. The Assembly is also responsible for tracking scientific developments that easily translate into better diagnostic technologies or enhanced patient care The Assembly is comprised of the following three groups:

Molecular Pathology and Functional Genomics

Group 03.01
Chair: Philippe Bonniaud
Secretary: Aurélie Fabre

Airway Cell Biology and Immunopathology

Group 03.02
Chair: Silke Meiners
Secretary: Irene Heijink

Mechanisms of Lung Injury and Repair

Group 03.03
Chair: Melanie Koenigshoff
Secretary: Boots Agnes W.

ERS Assembly 4: Clinical physiology and sleep

Head: Andrea Aliverti

Secretary: Pierantonio Laveneziana

Assembly Early Career representative: Isaac Almendros

Assembly 4 covers a range of topics that provide important links between research and clinical medicine. It has broad scope and includes integrative aspects of respiratory physiology, sleep apnoea and associated health problems and cellular and molecular physiology.
The Assembly is comprised of the following three groups:

Clinical respiratory physiology, exercise and functional imaging

Group 04.01
Chair: Samuel Verges
Secretary: Sam Bayat

Sleep and Control of Breathing

Group 04.02
Chair: Winfried Randerath
Secretary: Ramon Farré

ERS Assembly 5: Airway Diseases

Head: Antonio Spanevello

Secretary: Omar Usmani

Assembly Early Career representative: Alexander Mathioudakis

A substantial number of pharmacologists and basic scientists have joined the clinicians in Assembly 5. The major disease focus of the Assembly is translational research in asthma, COPD and cough with additional interests in non-CF bronchiectasis, bronchiolitis and upper airways.

The groups within the Assembly examine the immunology and pathobiology of these diseases; monitoring of disease and devices for drug delivery; the pharmacology of drugs in disease and in models of disease; and the use of big data and systems analysis of chronic airways diseases. The Assembly collaborates with other Assemblies in areas of joint interest including cell and molecular biology, paediatrics, infection and occupation and epidemiology.

The Assembly is comprised of the following three groups:

Airway Pharmacology and Treatment

Group 05.01
Chair: Reinoud Gosens
Secretary: Paul Kirkham

Monitoring Airway Disease

Group 05.02
Chair: Jose Luis Lopez-Campos
Secretary: Schleich Florence

Allergy and Immunology

Group 05.03
Chair: Apostolos Bossios
Secretary: Idzko Marco

ERS Assembly 6: Epidemiology and Environment

Head: Christer Janson

Secretary: Charlotte Suppli-Ulrik

Assembly Early Career representative: Andre Amaral

This is an interdisciplinary Assembly, which includes not only pulmonologists, but also epidemiologists, clinicians, statisticians, occupational doctors, air pollution scientists and health educators. Smoking and the environment are important issues for respiratory disease and this Assembly is involved in many activities to promote public awareness and scientific research in the field.
Members of the Assembly welcome collaboration with other Assemblies to work on common programmes. The Assembly is comprised of the following four groups:

Epidemiology

Group 06.01
Chair: Anne Lindberg
Secretary: Quint Jennifer

Occupational and Environmental Health

Group 06.02
Chair: David Fishwick
Secretary: Rafael De La Hoz

Tobacco, Smoking Control and Health Education

Group 06.03
Chair: Sofia Ravara
Secretary: Elif Dagli

Genes and environment

Group 06.04
Chair: Seif Shaheen
Secretary: Melén Erik

ERS Assembly 7: Paediatrics

Head: Jonathan Grigg

Secretary: Marielle Pijnenburg

Assembly Early Career representative: Raffaella Nenna

The mission of the Paediatric Assembly is to promote knowledge and understanding of paediatric respiratory diseases and advance the respiratory health of children in Europe and around the world. To achieve these goals, the Paediatric Assembly provides a platform for interaction between clinicians and researchers and ensures that educational and scientific needs are met during the annual Congresses. The seven scientific Groups of this Assembly represent paediatric counterparts to the other Groups and Assemblies of ERS.
The Assembly is comprised of the following seven groups:

Paediatric Respiratory Physiology and Sleep

Group 07.01
Chair: Graham L. Hall
Secretary: Refika Hamutcu Ersu

Paediatric Asthma and Allergy

Group 07.02
Chair: Bart Rottier
Secretary: Angela Zacharasiewicz

Cystic Fibrosis

Group 07.03
Chair: Jürg Barben
Secretary: Alex Horsley

Paediatric Respiratory Infection and Immunology

Group 07.04
Chair: Fernandes Ricardo Miguel Ribeiro Marques Cunha
Secretary: Marijke Proesmans

Neonatology and Paediatric Intensive Care

Group 07.05
Chair: Christoph Charles Roehr
Secretary: Suzanne Terheggen-Lagro

Paediatric Respiratory Epidemiology

Group 07.06
Chair: Bulent Taner Karadag
Secretary: Liesbeth Duijts

Paediatric Bronchology

Group 07.07
Chair: Deborah Snijders
Secretary: Dirk Schramm

Lung and airway developmental biology

Group 07.08
Chair: Robbert Rottier
Secretary: Silvia Carraro

ERS Assembly 8: Thoracic Surgery and Transplantation

Head: Geert Verleden

Secretary: Elia Stefano

Assembly Early Career representative: Elodie Lhuillier

Assembly 8 includes physicians and surgeons with an extraordinary knowledge of the state of the art in the field of Lung Transplantation and Thoracic Surgery. Its groups are strongly engaged collaborative work with the other Scientific Assemblies, focussing on surgical options for the treatment of lung diseases.
The Assembly is comprised of the following two groups:

Thoracic Surgery

Group 08.01
Chair: Tezel Cagatay
Secretary: Bertolaccini Luca

Transplantation

Group 08.02
Chair: Christian Benden
Secretary: Vos Robin

ERS Assembly 9: Allied Respiratory Professionals

Head: Irene Steenbruggen

Secretary: Martijn A. Spruit

Assembly Early Career representative: Jana De Brandt

It is increasingly recognised that allied healthcare professionals play an important role in the diagnosis, treatment and care of patients with pulmonary diseases. This Assembly is an opportunity to learn from each other's disciplines and achieve better patient outcomes.
The Assembly is comprised of the following three groups:

Respiratory Function Technologists/Scientists

Group 09.01
Chair: Aisling Mcgowan
Secretary: Karl Sylvester

Physiotherapists

Group 09.02
Chair: Daniel Langer
Secretary: Deniz Inal-Ince

Nurses

Group 09.03
Chair: Janelle Yorke
Secretary: Russell Anne-Marie

ERS Assembly 10: Respiratory Infections

Head: Graham Bothamley

Secretary: Eva Polverino

Assembly Early Career representative: Aran Singanayagam

The Infectious Diseases Assembly covers all issues of pulmonary and respiratory infections with a strong focus on pneumonia and antibiotic resistance, bronchiectasis, tuberculosis and non-tuberculous mycobacteria. This Assembly is one of the largest scientific assemblies of the ERS. Airway and pulmonary infections play an important role for outpatient, clinical and intensive care medicine in children and adults and the topics covered by the Assembly include bacterial, viral, fungal and parasitic infections. Prevention of infections and the emergence of antibiotic resistance play an important role in its scientific and educational activities and in interactions with the other Scientific Assemblies in the ERS. Members of the Assembly, especially the juniors, are engaged in educational activities through the ERS school and in large collaborative research networks including:


  • The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) www.bronchiectasis.eu

  • The European Network for ICU-related respiratory infections (ENIRRI)
  • The TBNET www.tb-net.org


There are two groups within Assembly 10:

Respiratory Infections

Group 10.01
Chair: James Chalmers
Secretary: Michael Loebinger

Tuberculosis

Group 10.02
Chair: Raquel Almeida Ferreira Duarte Bessa Melo
Secretary: Jan Heyckendorf

ERS Assembly 11: Thoracic Oncology

Head: Nir Peled

Secretary: Bogdan Dragos Grigoriu

Assembly Early Career representative: Nina Bostantzoglou

Respiratory tumours are a major part of daily practice for many respiratory physicians. Assembly 11 focuses on all aspects of lung cancer, mesothelioma, mediastinal tumours and lung metastases. The work of members includes epidemiology and prevention; biology and pathology; diagnosis and staging; multidisciplinary approaches in therapy; systemic treatment with chemotherapy and targeted agents; and follow-up and supportive care. There is a close cooperation with theImaging, Interventional Respiratory Medicine, Radiotherapy, Biology and Thoracic Surgery Groups, now formalised into the Thoracic Oncology Network of the ERS. The Assembly aims to reinforce the role of respiratory physicians in this area practice by establishing practice guidelines, cooperating with other societies and organising dedicated school courses and symposia on contemporary clinical questions. The Assembly has developed an action plan for Thoracic Oncology in Europe, fully supported by the ERS Executive Committee. The ongoing actions include the creation of a Task Force for quality management of lung cancer or the development of a multidisciplinary HERMES programme for training in thoracic oncology.
The Assembly is comprised of the following two groups:

Lung Cancer

Group 11.01
Chair: Torsten Blum
Secretary: Matthew Evison

Pleural and Mediastinal Malignancies

Group 11.02
Chair: Nick Maskell
Secretary: Sotirios Zarogiannis

ERS Assembly 12: Interstitial Lung Diseases

Head: To be announced

Secretary: To be announced

Assembly Early Career representative: To be announced

There are four groups within Assembly 12:

Idiopathic interstitial pneumonias

Group 12.01
Chair: To be announced
Secretary: To be announced

ILD/DPLD of known origin

Group 12.02
Chair: To be announced
Secretary: Chair: To be announced

Sarcoidosis and other granulomatous ILD/DPLD

Group 12.03
Chair: To be announced
Secretary: Chair: To be announced

Rare ILD/DPLD

Group 12.04
Chair: To be announced
Secretary: Chair: To be announced

ERS Assembly 13: Pulmonary Vascular Diseases

Head: To be announced

Secretary: To be announced

Assembly Early Career representative: To be announced

There are three groups within Assembly 13:

Pulmonary hypertension

Group 13.01
Chair: To be announced
Secretary: To be announced

Pulmonary embolism

Group 13.02
Chair: To be announced
Secretary: To be announced

Right ventricle

Group 13.03
Chair: To be announced
Secretary: To be announced